Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Research indicates that there are numerous differences in how HIV behaves in women versus men.
The new coronavirus crisis has upended the clinical trials process around the world.
A recent study of noncommunicable disease found mood disorders were linked to metabolic syndrome in particular.
Studies have found that weight gain is common after people with HIV begin an antiretroviral in this class.
Tests like the one approved this week can show who is likely to be immune, but it’s not yet clear how long such immunity lasts.
Researchers found that during the earliest phases of infection, the reservoir is quite susceptible to antiretroviral treatment.
Researchers attribute this dramatic shift to routine testing and access to direct-acting antiviral treatment for hep C.
A recent Japanese study found that this risk reduction was greater than that associated with the hep B vaccine.
Researchers found that among those older than 50, lung function declined at a comparable rate regardless of HIV status.
The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.
Researchers found that the more people with HIV drank, the lower a biomarker of bone formation.
New York City’s department of health issues recommendations on navigating sex when social distancing is the name of the game.
The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment.
Alabama state pandemic guidance advises denying ventilators for use by people with metastatic cancer, AIDS and end-stage liver disease.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.